Document is current

Any future updates will be listed below

Adverse Events Reported with Therapies Targeting the CGRP Pathway During the First 6 Months Post-launch: A Retrospective Analysis Using the FDA Adverse Events Reporting System

Crossref DOI link: https://doi.org/10.1007/s12325-022-02346-4

Published Online: 2022-11-09

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark